Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11833119 Combination therapies for the treatment of hepatocellular carcinoma

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Peter Smith0

Anand Selvaraj0

Date of Patent

December 5, 2023

0

Patent Application Number

169612920

Date Filed

January 9, 2019

0

Patent Citations

US Patent 10736900 Combinations of an FGFR inhibitor and an IGF1R inhibitor

0

US Patent 9006256 Antitumor agent for thyroid cancer

0

US Patent 9434697 Pyrimidine FGFR4 inhibitors

0

US Patent 7253286 Nitrogen-containing aromatic derivatives

0

US Patent 7612208 Crystalline form of the salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide or the solvate of the salt and a process for preparing the same

0

Patent Primary Examiner

Celeste A Roney

0

Patent abstract

Provided herein is a combination therapy useful for the treatment hepatocellular carcinoma. The combination comprises an FGFR4 inhibitor and lenvatinib.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11833119 Combination therapies for the treatment of hepatocellular carcinoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool